Note: An earlier version of this post, drafted by Eric A. Friedman, O’Neill Institute Law Fellow and Lawrence O. Gostin, O’Neill Institute Faculty Director, was disseminated as an O’Neill Institute Briefing on May 18, 2011.
In late May, the World Health Assembly (WHA) discussed an ambitious agenda of reform of the World Health Organization (WHO) and global governance for health—the norms, institutions, and processes that collectively shape the health of the world’s population. This post discusses WHA agenda items of major importance.
The WHO faces at least a $300 million budget deficit and finds itself in an increasingly complex global health architecture characterized by great passion and innovation, but also fragmentation and lack of global leadership. Recognizing the need for reform to be more relevant to contemporary realities and to assume its proper global health leadership role, the World Health Organization is initiating a major reform process.
The WHO reform agenda includes: (1) a proposal for a global stakeholders’ forum to help shape the global health agenda; (2) clearer articulation of WHO’s unique role and functions; and (3) managerial reforms within WHO to increase its accountability to Member States, improve organizational structure, and revise its human resource strategy. One thing to look out for: the risk that as WHO seeks to define and organize itself along particular functions, such key areas as human rights, gender, primary health care, and the social determinants of health, which are officially to be “mainstreamed,” could in practice see their place within WHO downgraded.
Last month in the Journal of the American Medication Association, O’Neill Institute Faculty Director, Lawrence Gostin, and Devi Sridhar from Oxford University offered five key proposals for reform.
Sridhar and Gostin propose:
The Indonesia Virus Sharing Controversy
In April, Margaret Chan, WHO Director-General, announced a landmark agreement on sharing novel influenza viruses and on equitable benefits for access to vaccines and pharmaceuticals. When Indonesia refused to share Influenza (A) H5N1 (avian influenza) with WHO, it raised a major global health and diplomatic challenge. One of the key questions that emerged was how developing countries would be able to access the vaccines and medicines needed to protect their populations against these viruses. The concern about lack of such access is what had prompted Indonesia to take its stand against sharing the virus with WHO.
The World Health Assembly is expected to adopt a framework on pandemic influenza preparedness that addresses this issue (as well as sharing influenza viruses), though only in limited ways, making the framework historic yet still a work in progress. It encourages Member States to urge industry to contribute to a WHO stockpile of vaccine doses to be distributed to developing countries and to contain initial outbreaks, to implement tiered pricing schemes for vaccines and antivirals, and to transfer technology to developing countries for developing and producing influenza vaccines. However, the framework does not place binding obligations on states.
Emerging Global Health Priorities
As part of the WHA’s packed agenda, there will be a major discussion emerging a global health priorities, including universal health coverage; health workforce; and national health plans, urging them to be based on primary health care principles and address social determinants of health.
The WHA will also be addressing long under-prioritized issues of injuries (in particular, child injuries); and non-communicable diseases. The NCD discussion is preparation of the UN high-level meeting on that topic in September. The WHA will also cover more traditional and vitally important health issues as addressed by the Millennium Development Goals.
Signup for our mailing list and stay up to date on the latest happenings at The O’Neill Institute
Or sign up for our RSS Feed
The views reflected in this blog are those of the individual authors and do not necessarily represent those of the O’Neill Institute for National and Global Health Law or Georgetown University. This blog is solely informational in nature, and not intended as a substitute for competent legal advice from a licensed and retained attorney in your state or country.